Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives

Obstructive sleep apnea syndrome (OSAS) is characterized by recurrent episodes of upper airway collapse associated with oxygen desaturation and sleep disruption. It is proposed that these periodic changes lead to molecular variations that can be detected by assessing serum biomarkers. Studies have identified inflammatory, oxidative, and metabolic perturbations attributable to sleep-disordered breathing. Given that OSAS is associated with increased cardiovascular and cerebrovascular morbidity, the ideal biomarker should enable timely recognition with the possibility of intervention. There is accumulating data on the utility of serum biomarkers for the evaluation of disease severity, prognosis, and response to treatment. However, current knowledge is limited by data collection techniques, disease complexity, and potential confounding factors. The current paper reviews the literature on the use of serum biomarkers in OSAS. It is concluded that the ideal serum biomarker still needs to be discovered, while caution is needed in the interpretation of hitherto available results.

• Publication year

  2014

• Venue

  Pulmonary Medicine

• Publication date

  2014-11-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2014/930535PMID 25538852PMCID 4265695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive biomarker profiling in patients with obstructive sleep apnea.

  2015cited by this paper
• Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients

  2014influential reference
• Correlation between Inflammatory Markers of Atherosclerosis and Carotid Intima-Media Thickness in Obstructive Sleep Apnea

  2014cited by this paper
• Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea.

  2014cited by this paper
• Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS

  2014cited by this paper
• Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis

  2013cited by this paper
• Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis

  2013cited by this paper
• Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept

  2013cited by this paper
• Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia

  2013cited by this paper
• Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea

  2013cited by this paper
• Effect of hypoxia on glucose metabolism in nondiabetic patients with obstructive sleep apnea syndrome.

  2013cited by this paper
• Efecto de la hipoxia sobre el metabolismo de la glucosa en pacientes no diabéticos con síndrome de apnea obstructiva del sueño

  2013cited by this paper
• Effect of Hypoxia on Glucose Metabolism in Nondiabetic Patients With Obstructive Sleep Apnea Syndrome

  2013cited by this paper
• Serum Inflammatory Markers in Obstructive Sleep Apnea: A Meta-Analysis

  2013influential reference
• Plasma selectins in patients with obstructive sleep apnea.

  2013cited by this paper
• Oxidative stress in patients with obstructive sleep apnea syndrome

  2013influential reference
• Sleep apnoea syndrome and 10‐year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance

  2013cited by this paper
• Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles.

  2013cited by this paper
• Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events.

  2013cited by this paper
• Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status.

  2012cited by this paper
• [Relation of serum levels of C-reactive protein to anthropometric meaurements; a sustematic review of studies in South America].

  2012cited by this paper
• The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea

  2012cited by this paper
• Continuous positive airway pressure and type 2 diabetes mellitus.

  2012cited by this paper
• Effect of Continuous Positive Airway Pressure on Hemoglobin A1c in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-analysis

  2012cited by this paper
• RELACIÓN ENTRE LOS NIVELES SÉRICOS DE LA PROTEÍNA C REACTIVA Y MEDIDAS ANTROPOMÉTRICAS; UNA REVISIÓN SISTEMÁTICA DE LOS ESTUDIOS REALIZADOS EN SURAMÉRICA

  2012cited by this paper
• Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events.

  2012cited by this paper
• The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort.

  2012cited by this paper
• Independent Association Between Obstructive Sleep Apnea Severity and Glycated Hemoglobin in Adults Without Diabetes

  2012cited by this paper
• Lack of Effect of Sleep Apnea on Oxidative Stress in Obstructive Sleep Apnea Syndrome (OSAS) Patients

  2012cited by this paper
• The association of oxidative stress with central obesity in obstructive sleep apnea

  2012cited by this paper
• Effects of 10 days of modest intermittent hypoxia on circulating measures of inflammation in healthy humans

  2012cited by this paper
• The influence of obesity and obstructive sleep apnea on metabolic hormones

  2012cited by this paper
• Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome

  2012cited by this paper
• Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).

  2012cited by this paper
• Continuous Positive Airway Pressure Therapy Improves Vascular Dysfunction and Decreases Oxidative Stress in Patients With the Metabolic Syndrome and Obstructive Sleep Apnea Syndrome

  2012cited by this paper
• Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues

  2012cited by this paper
• The Association Among Lipoprotein-associated Phospholipase A2 Levels, Total Antioxidant Capacity and Arousal in Male Patients with OSA

  2011cited by this paper
• Sleep Architecture and Glucose and Insulin Homeostasis in Obese Adolescents

  2011cited by this paper
• Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease

  2011cited by this paper
• Leptin and the regulation of body weigh.

  2011cited by this paper
• Biochemical oxidative stress-related markers in patients with obstructive sleep apnea

  2011cited by this paper
• Weight and metabolic effects of cpap in obstructive sleep apnea patients with obesity

  2011cited by this paper
• Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis

  2011cited by this paper
• Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome

  2011cited by this paper
• Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels

  2011influential reference
• Cysteine: a potential biomarker for obstructive sleep apnea.

  2011cited by this paper
• Vascular Dysfunction in Obstructive Sleep Apnea and Type 2 Diabetes Mellitus

  2011cited by this paper
• Could vitamins be helpful to patients with sleep apnea?

  2011cited by this paper
• 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans

  2010influential reference
• Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome.

  2010cited by this paper
• Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?

  2010cited by this paper
• Heat‐shock protein 70: expression in monocytes of patients with sleep apnoea and association with oxidative stress and tumour necrosis factor‐α

  2010cited by this paper
• Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea

  2010cited by this paper
• Relationship of oxidative stress and endothelial dysfunction in sleep apnoea

  2010cited by this paper
• Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome.

  2009cited by this paper
• HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men

  2009cited by this paper
• The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea

  2009cited by this paper
• Oxidative stress--a unifying paradigm in obstructive sleep apnea and comorbidities.

  2009cited by this paper
• Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation.

  2009cited by this paper
• Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea

  2009influential reference
• Effects of Nasal Continuous Positive Airway Pressure Treatment on Oxidative Stress and Adiponectin Levels in Obese Patients with Obstructive Sleep Apnea

  2009cited by this paper
• Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea.

  2009cited by this paper
• Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males

  2009cited by this paper
• Sleep duration and biomarkers of inflammation.

  2009cited by this paper
• Increased Cellular Proliferation and Inflammatory Cytokines in Tonsils Derived From Children With Obstructive Sleep Apnea

  2009cited by this paper
• Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control?

  2009cited by this paper
• Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome

  2009cited by this paper
• Paraoxonase: a multifaceted biomolecule.

  2009cited by this paper
• The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome

  2008cited by this paper
• Plasma Thioredoxin, a Novel Oxidative Stress Marker, in Patients with Obstructive Sleep Apnea Before and After Nasal Continuous Positive Airway Pressure

  2008cited by this paper
• Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial

  2008cited by this paper
• Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea.

  2008cited by this paper
• Comparison of Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels between Patients with and without Obstructive Sleep Apnea Syndrome

  2008cited by this paper
• Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome.

  2008influential reference
• Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.

  2008cited by this paper
• Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial

  2008cited by this paper
• Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk

  2008cited by this paper
• Reduced paraoxonase 1/arylesterase activity and its post-therapeutic increase in obstructive sleep apnea syndrome: a preliminary study.

  2008cited by this paper
• Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome.

  2008cited by this paper
• Resistin Is Closely Related to Systemic Inflammation in Obstructive Sleep Apnea

  2008cited by this paper
• Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity

  2007cited by this paper
• Free radicals and antioxidants in normal physiological functions and human disease.

  2007cited by this paper
• A new prognostic marker for obstructive sleep apnea: hepcidin.

  2007cited by this paper
• Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome.

  2007cited by this paper
• Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome.

  2007cited by this paper
• Circulating ICAM-1 and VCAM-1 Levels in Patients with Obstructive Sleep Apnea Syndrome

  2006influential reference
• Hypoxia‐sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome

  2006cited by this paper
• Serum Adiponectin Levels in Adult Male Patients with Obstructive Sleep Apnea Hypopnea Syndrome

  2006cited by this paper
• Matrix metalloproteinases and cardiovascular disease.

  2006cited by this paper
• Recent advances in the relationship between obesity, inflammation, and insulin resistance.

  2006cited by this paper
• Sleep-Disordered Breathing and Acute Ischemic Stroke: Diagnosis, Risk Factors, Treatment, Evolution, and Long-Term Clinical Outcome

  2006cited by this paper
• HDL dysfunction in obstructive sleep apnea.

  2006cited by this paper
• Oxidative stress in obstructive sleep apnoea.

  2005cited by this paper
• Review article: adipocytokines and insulin resistance

  2005cited by this paper
• Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome

  2005cited by this paper
• Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study

  2005cited by this paper
• Adipose tissue, adipokines, and inflammation.

  2005cited by this paper
• Altered Blood Rheology in Obstructive Sleep Apnea as a Mediator of Cardiovascular Risk

  2005cited by this paper
• Sleep apnea is a manifestation of the metabolic syndrome.

  2005cited by this paper
• The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.

  2004cited by this paper

• Integrative analysis of candidate MicroRNAs and gene targets for OSA management using in silico and in-vitro approach

  2025cites this paper
• Usefulness of Blood Biomarkers in Screening Patients with Obstructive Sleep Apnea: Could Albumin Indices and Uric Acid-to-HDL Ratio Be New OSAS Severity Indices?

  2025cites this paper
• Melatonin and Cortisol Concentration Before and After CPAP Treatment of Obstructive Sleep Apnea

  2025cites this paper
• A Retrospective Study on the Association of the Systemic Inflammatory Response Index in Predicting the Severity of Obstructive Sleep Apnea

  2025cites this paper
• Machine Learning-Based Analysis of Salivary Proteomic Signatures in Catathrenia

  2025cites this paper
• Sex-specific differences in overnight nitrate levels in persons with obstructive sleep apnea and type 2 diabetes.

  2025cites this paper
• A Systematic Review and Meta-Analysis of Mean Platelet Volume and Platelet Distribution Width in Patients with Obstructive Sleep Apnoea Syndrome

  2024cites this paper
• Oxidative Stress in the Pathogenesis of Oral Cancer

  2024cites this paper
• Impact of Intermittent Hypoxia Related to Obstructive Sleep Apnoea Syndrome on Low-Grade Inflammation in Hypertensive Patients: Potential Implications for Cardiovascular Risk

  2024cites this paper
• Systemic inflammatory response index as an independent predictor of severity in patients with obstructive sleep apnea

  2024cites this paper
• Association between Red Blood Cell Distribution Width and Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis

  2023cites this paper
• Salivary biomarker C-reactive protein levels in children with sleep problems and Class II malocclusion before and after twin-block therapy

  2023cites this paper
• Research Progress on the Relationship between Red Cell Distribution Width, Mean Platelet Volume and OSAHS-COPD Overlap Syndrome

  2023cites this paper
• Autoantibodies of inflammatory cytokines as serum biomarkers in OSA patients.

  2023cites this paper
• Validation of NoSAS score for the screening of obstructive sleep apnea

  2023cites this paper
• Obstrüktis Uyku Apnesi Olan Hastalarda Hastalık Şiddeti ile CRP/Prealbümin Oranı Arasındaki İlişki

  2022cites this paper
• Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure

  2022cites this paper
• Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study

  2022cites this paper
• Salivary C-reactive Protein as a Biomarker in Children with Sleep Disorders: An Evaluative Study

  2022cites this paper
• Inflammatory Biomarkers for Children with Sleep Disorders: A Review

  2022cites this paper
• Current and future strategies for diagnostic and management of obstructive sleep apnea

  2021cites this paper
• Salivary biomarkers associated with obstructive sleep apnea: a systematic review

  2021cites this paper
• Cardiovascular disease in patients with chronic obstructive pulmonary disease, obstructive sleep apnoea syndrome and overlap syndrome.

  2020cites this paper
• Serum Copeptin Levels in Obstructive Sleep Apnea

  2020cites this paper
• Linking Vitamin D and Sleep

  2020cites this paper
• The Relation between Obstructive Sleep Apnea Syndrome and Vitamin D

  2020cites this paper
• Advances and challenges in pursuing biomarkers for obstructive sleep apnea: Implications for the cardiovascular risk.

  2020cites this paper
• Biomarkers for Temporomandibular Disorders: Current Status and Future Directions

  2020cites this paper
• The role of the external nasal measures of patients with sleep disordered breathing in determining disease severity

  2020cites this paper
• Technologic advances in the assessment and management of obstructive sleep apnoea beyond the apnoea-hypopnoea index: a narrative review

  2020cites this paper
• Analysis of vitamin D Receptor Polymorphisms in Turkish Patients with Obstructive Sleep Apnea Syndrome

  2019cites this paper
• Sex-Specific Differential Responses of Circulating Biomarkers in Obstructive Sleep Apnea Treatment: a Post-hoc Analysis of a Randomized Controlled Trial.

  2019cites this paper
• Mean Platelet Volume and Platelet Distribution Width in Patients With Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease

  2018cites this paper
• Metabolic Syndrome and Vitamin D Levels in Patients with Obstructive Sleep Apnea Syndrome

  2018cites this paper
• Impairment of vascular strain in patients with obstructive sleep apnea

  2018cites this paper
• The role of vitamin D in obstructive sleep apnoea syndrome

  2018cites this paper
• Comment on: Comorbidities in coexisting chronic obstructive pulmonary disease and obstructive sleep apnea - overlap syndrome.

  2018cites this paper
• Canvassing the aetiology, prognosis and molecular signatures of obstructive sleep apnoea

  2018cites this paper
• Toward a Blood-Borne Biomarker of Chronic Hypoxemia: Red Cell Distribution Width and Respiratory Disease.

  2017cites this paper
• Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea.

  2017cites this paper
• C‐reactive protein improves the ability to detect cardiometabolic risk in mild‐to‐moderate obstructive sleep apnea

  2017cites this paper
• Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome.

  2017cites this paper
• Obstructive Sleep Apnea as the Initial Manifestation of Acromegaly

  2017cites this paper
• Viejos biomarcadores, ¿nuevas utilidades en enfermedad pulmonar obstructiva crónica y apnea obstructiva del sueño?

  2017cites this paper
• A multicenter matched case-control analysis on seven polymorphisms from HMGB1 and RAGE genes in predicting hepatocellular carcinoma risk

  2017cites this paper
• Increased Carotid Intima–Media Thickness in Obstructive Sleep Apnea: An Additional Issue to Consider

  2017cites this paper
• New Uses for Old Biomarkers in COPD and Obstructive Sleep Apnea

  2017cites this paper
• OSAHS: Another Independent Risk Factor of Type 2 Diabetes

  2017cites this paper
• New Uses for Old Biomarkers in chronic obstructive pulmonar disease and Obstructive Sleep Apnea?

  2017cites this paper
• Erythrocyte deformability, plasma lipid peroxidation and plasma protein oxidation in a group of OSAS subjects

  2016cites this paper
• Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome

  2016cites this paper
• Troubles du sommeil et prise en charge proposée dans une population d'enfants et d'adolescents en surpoids ou obèses suivis par le RéPPOP Aquitaine

  2016cites this paper
• An Update on Obstructive Sleep Apnea

  2016cites this paper
• Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome.

  2016cites this paper
• The relationship between obstructive sleep apnoea and coronary heart disease

  2015cites this paper
• Chromatography/Mass Spectrometry-Based Biomarkers in the Field of Obstructive Sleep Apnea

  2015cites this paper
• Copeptin: a new predictor for severe obstructive sleep apnea

  2015cites this paper